Skip to main navigation Skip to search Skip to main content

Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

Translated title of the contribution: Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
  • M. Peipp
  • , T. Schneider-Merck
  • , M. Dechant
  • , T. Beyer
  • , J.J. Lammerts van Bueren
  • , W.K. Bleeker
  • , P.W.H.I. Parren
  • , J.G.J. van de Winkel
  • , T. Valerius

Research output: Contribution to journal › Article › Academic › peer-review

3 Downloads (Pure)
Translated title of the contributionTumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.
Original languageUndefined/Unknown
Pages (from-to)4338-4345
Number of pages8
JournalJournal of Immunology
Volume180
Issue number6
Publication statusPublished - 2008

Access to Document

    Cite this